Sales of Intravenous Iron Drugs Market is Estimated to hit US$ 6.3 Bn at a CAGR of 8.5% by year 2032-end | Future Market Insights, Inc.

Global Intravenous Iron Drugs Market was valued at US$ 2.6 Bn in 2021 and is expected to reach US$ 6.3 Bn by 2032, finds Fact.MR in a recent market survey. As per the findings of the report, Intravenous Iron Drugs revenue through Ferric Carboxymaltose will garner significant demand in the market as the bulk of revenue will …

Over-The-Counter (OTC) Veterinary Drugs Market is projected to reach US$ 18.14 Bn by 2032 at a CAGR of 8.1%

Over the forecast period (2022-2032), it is expected that worldwide sales of Over-The-Counter (OTC) Veterinary Drugs Market medications would increase at a CAGR of 8.1% and reach US$ 18.14 Bn by the end of 2032. In 2021, online pharmacies held a market share of more than 38%. According to Future Market Insights, the global over-the-counter (OTC) …

IoT in Healthcare Market is projected to grow at a CAGR of 18.0%, reaching US$ 952.3 Billion by 2032 | FMI

[297 Pages Report] The global IoT in healthcare market is projected to reach US$ 181.4 Billion in 2022, anticipated to grow at a CAGR of 18.0%, reaching US$ 952.3 Billion by 2032. The market is slated to document a Y-o-Y growth rate of 20.7% from 2021-2022, increasing from the previously registered value of US$ 150.3 Billion. By …

Oligonucleotide API Market is expected to expand at a CAGR of 10.2% through 2030

The global Oligonucleotide API Market is expected to reach US$ 2.46 billion in 2022, with a CAGR of 10.2% through 2030, according to FMI, an ESOMAR-certified market research firm. According to FMI’s analysis, as of now, 100+ oligonucleotide APIs are in the clinical trials’ phase, and regulatory approval is on the cards. Post-approval, the demand …

Keloid Treatment Market Size expected to reach a valuation of US$ 5.1 Bn by the end of 2032 | FMI

The global keloid treatment market size reached US$ 3.6 Bn in 2021 and is expected to enjoy a valuation of US$ 3.7 Bn by the end of 2022. Furthermore, with rising prevalence of keloid across the world, the overall demand for keloid treatment is set to grow at 3.2% CAGR between 2022 and 2032, totalling a valuation of ~US$ 5.1 Bn by 2032. Global Keloid Treatment Market: …

Light Curable Flowable Composite Market Detailed Survey On Key Trends, Leading Players & Revolutionary Opportunities 2027

Future Market Insights (FMI) presents its new, comprehensive study on the global Light Curable Flowable Composite market spanning from 2017 to 2027. Researches at FMI have no left no stone unturned in bestowing readers a comprehensive view of the market, by studying the drivers, trends, challenges, and restraints. Backed by historical data and projected data, the report …

Radiation-Induced Fibrosis Treatment Market is set to witness a 5.6% growth during the year 2022-2031

According to the latest research by Future Market Insights, Radiation-Induced Fibrosis Treatment market is set to witness a 5.6% growth during the year 2021-2031. The market is expected to witness growth owing to increase in number of patients going through radiotherapy  or chemotherapy and the growing utilization of novel drug delivery methods like transdermal patches & combination therapies. …

Radioimmunotherapy Treatment Market Industry Analysis, Opportunities, Technology, Demand, Top Players and Growth Forecast 2027

Cancer is a leading cause of death worldwide and is projected to rise with an estimated 11.5 million deaths in 2030. The most common cancer is lung cancer, accounting about 1.59 million deaths, other types of cancer include liver cancer, breast cancer, stomach cancer, liver cancer, etc. Gain complete access to the report @ https://www.futuremarketinsights.com/reports/radioimmunotherapy-treatment-market …

Retinoids Market is projected to reach US$ 2.5 Bn by the end of 2032 | FMI

[250 Pages Report] The global demand for retinoids is expected to rise at a healthy CAGR of 5.4% per year to US$ 1.5 billion in 2022 Retinoids market is anticipated to grow with a significant growth rate over the forecast period 2018-2028. Retinoids are generally prescribed by dermatologists for mild to moderate acne. Retinoids generally come in three …

Saudi Arabia Pharmaceutical Market is predicted to be worth US$ 5,209.5 Mn by the end of 2022, at a CAGR of 9.6% from (2022–2032)

The Saudi Arabia pharmaceutical market is estimated to be valued at US$ 5,209.5 Mn by 2016 end and is expected to expand at a CAGR of 9.0% over the forecast period (2016–2026). The significant rise in lifestyle-related diseases and the developments in healthcare infrastructure are expected to influence the demand for pharmaceuticals in Saudi Arabia. In 2016, …